Topic: supply chain

Teva will begin producing chemo drug vincristine in the U.S. but has resisted the idea that its withdrawal from the market led to a shortage.

An FDA warning letter lays out failures by a Torrent Pharmaceuticals plant that figures into the global recall of tainted high blood pressure meds.

Pfizer's role as the hero in ramping up production of a chemo drug badly needed by pediatric oncologists is a turnabout for the drugmaker.

With hundreds of drug shortages hitting the pharmaceutical industry each quarter, Merck KGaA is hoping a novel machine-learning platform will help.

Interruptions continue to wreak havoc on the global drug supply as drugmakers respond to the detection of impurities in some commonly used meds.

With Brexit now set for Oct. 31, drugmakers will find out whether three years of planning and investments will keep their supply chains intact.

Swine fever in China has forced one of the largest manufacturers of heparin to begin limiting allocations of the treatment.

Drugmakers have speculated about delivering temperature-sensitive vaccines and drugs using drones. Now, Merck & Co. is testing the method. 

Teva is recalling 10 more lots of losartan as blood pressure drugs tainted with suspected carcinogens continue to pop up in the U.S. supply chain.

There has been a lot of talk about how blockchain technology can better protect the U.S. drug supply chain. Merck intends to test that theory.